RT Book, Section
A1 MacDonald, Deborah J.
A2 Kuerer, Henry M.
SR Print(0)
ID 6406041
T1 Chapter 7. Establishing a Cancer Genetics Service
T2 Kuerer's Breast Surgical Oncology
YR 2010
FD 2010
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-160178-8
LK accesssurgery.mhmedical.com/content.aspx?aid=6406041
RD 2024/04/25
AB Given  the  accumulating  evidence  documenting  the  efficacy  of  genetic  screening  and  risk-reduction  interventions,  genetic  cancer  risk  assessment  (GCRA)  has  become  a  medical  standard-of-care  option  for  persons  with  a  personal  and/or  family  history  of  cancer  suggestive  of  increased  cancer  risk.1-5  GCRA  utilizes  rapidly  evolving  genetic  technologies  along  with  established  empiric  risk  models  to  estimate  cancer  risk  and  provide  age-  and  risk-level  appropriate  cancer  prevention  and  risk-reduction  strategies  for  individuals  and  their  family  members.  The  ultimate  value  of  GCRA  is  the  opportunity  for  initiation  of  early  detection  or  risk-reducing  strategies  that  would  be  most  effective  in  minimizing  cancer  incidence,  morbidity,  and  mortality,  by  identifying  persons  at  increased  cancer  risk  prior  to  the  onset  of  an  initial  or  subsequent  cancer.